About the Disease
Cerebral Palsy (CP) is a non-progressive neurological condition mostly caused by damage to the developing brain before, during, or shortly after birth. It leads to problems with movement, posture, coordination, muscle tone, and sometimes speech or cognition. Because the brain damage is static (does not get worse over time), therapies aim to improve function, reduce symptoms, and harness neuroplasticity. Stem cell therapy for CP is being researched to help repair or protect damaged brain tissue, reduce inflammation, support regeneration, and improve motor outcomes
Institutes / Trials Offering Stem Cell Therapy for CP
Here are some of the clinics / research trials / centers working with stem cell therapy in CP:
- First Affiliated Hospital of Dalian Medical University, Dalian, China
- Running a clinical trial (“Neural Stem Cells Therapy for CP”, NCT03005249) using neural stem cells in children aged ~1-12 years. InClinicalTrials
- Also part of broader clinical research centers (Stem Cell Clinical Research Center; Regenerative Medicine Center) focusing on CP in that region. sjzsyj.com.cn+1
- Medica Institute – UK / International Patients
- Offers stem cell treatments for CP (own protocols using MSCs, cord blood etc.) combined with rehabilitation. They report motor improvements for their treated children over time. medicainstitute.com
- Swiss Medica Clinic
- Offers stem cell programs for CP, including donor stem cells infusion, patient assessment, follow-ups. Claims improvements in brain function. Swiss Medica
- Advancells (India, etc.)
- Provides stem cell therapy protocols for CP: free consultation, evaluation, use of MSCs etc. Advancells
- Clinical Trial Networks / Meta-Analyses
- Several RCTs and meta-analyses show that mesenchymal stem cell (MSC) transplantation (umbilical cord, bone marrow etc.) improves gross motor functions (GMFM) in children with CP over 3-12 months. Wiley Online Library+2PubMed+2
- Safety profile in trials is relatively good; adverse events are rare and not severe. PubMed+1
